Introduction

Rheumatoid arthritis (RA) is a systemic inflammatory disease affecting mainly multiple diarthrodial joints. Numerous cytokines are involved in the pathobiology of RA. There is an imbalance in the cytokine network of RA patients. Proinflammatory cytokines such as interleukin-1 (IL-1), IL-6 and tumor necrosis factor alpha (TNF-α) are excessively produced, however, anti-inflammatory cytokines such as IL-1Ra and IL-10 fail to respond to inflammatory status (1). Anemia of chronic disease is not infrequent during the clinical course of RA (2). Iron metabolism is impaired in chronic inflammatory diseases such as RA. Hepcidin is a liver derived small peptide hormone that functions both as a homeostatic regulator of iron metabolism and a mediator of inflammation
. The aim of the present study was to assess the role of hepcidin in anemia associated with RA.
T a b l e 1 . T r e a t me n t P r o f i l e i n An e mi c a n d No n -a n e mi c RA P a t i e n t s (10) .
Statistical analysis
The data were expressed as mean±standard deviation and median [mean±SD (median) 
Results
Baseline characteristics of the study groups are given in
T a b l e 2 . B a s e l i n e Ch a r a c t e r i s t i c s o f t h e S t u d y S u b j e c t s
T a b l e 3 . F r e q u e n c i e s o f An e mi a , L e v e l s o f He mo g l o b i n a n d S e r u m He p c i d i n i n Ac t i v e a n d I n a c t i v e RA P a t i e n t s
Active RA (n=17)
Inactive RA (n=23) (Fig. 1) (Table 4) .
Discussion
Hepcidin, a small, cystein-rich peptide (11, 12) , can affect both inflammation and red blood cell kinetics in health and disease. In this study, the highest circulating hepcidin levels were observed in RA patients with anemia and the lowest levels in healthy adults. In addition, patients with RA without anemia had higher circulating hepcidin levels compared to those with IDA. While the differences between groups of RA+a and IDA as well as groups of RA+a and HA were statistically significant, there were no statistically significant differences between the other groups. -/-cells (13) . IFN-β inhibited hepcidin transcription in both studies (3, 13 (4, 5, 21, 22 (21) . In addition, serum hepcidin levels are rapidly down-regulated by IL-6 blockage (22) . Hepcidin also inhibits iron absorbtion from the intestine in mice, contributing to hypoferremia (4, 5) . The other two pathogenetic mechanisms of hepcidin in chronic disease anemia are that hepcidin inhibits iron mobilization from macrophages in the reticuloendothelial system (6) and could inhibit erythroid colony formation in the bone marrow (23 (3, (24) (25) (26) 
The effects of inflammation, particularly the role of cytokines, on hepatocyte hepcidin mRNA expression has been previously investigated. Nemeth et al (3) demonstrated that IL-6 and lipopolysaccharide induced hepcidin mRNA expression in human hepatocytes, but IL-1 and TNF-α had no
F i g u r e 1 . T h e c o r r e l a t i o n s b e t we e n c i r c u l a t i n g h e p c i d i n a n d o t h e r p a r a me t e r s i n t h e RA g r o u p . A. S e r u m h e p c i d i n l e v e l s we r e i n v e r s e l y c o r r e l a t e d wi t h Hb l e v e l s ( r = -0 . 3 6 4 a n d p = 0 . 0 2 1 ) . B . S er u m h e p c i d i n l e v e l s we r e p o s i t i v e l y c o r r e l a t e d wi t h DAS 2 8 ( CRP ) s c o r e s ( r = 0 . 4 7 7 a n d p = 0 . 0 0 2 ) .
T a b l e 4 . P r e d i c t o r s f o r He mo g l o b i n L e v e l s i n RA P a t i e n t s
